Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group

PURPOSE: To investigate whether event-free survival (EFS) can be maintained among children and adolescents with intermediate-risk (IR) malignant germ cell tumors (MGCT) if the administration of cisplatin, etoposide, and bleomycin (PEb) is reduced from four to three cycles and compressed from 5 to 3...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Oncol
Main Authors: Shaikh, Furqan, Cullen, John W., Olson, Thomas A., Pashankar, Farzana, Malogolowkin, Marcio H., Amatruda, James F., Villaluna, Doojduen, Krailo, Mark, Billmire, Deborah F., Rescorla, Frederick J., Egler, Rachel A., Dicken, Bryan J., Ross, Jonathan H., Schlatter, Marc, Rodriguez-Galindo, Carlos, Frazier, A. Lindsay
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2017
Subjects:
ORIGINAL REPORTS
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455599/
https://ncbi.nlm.nih.gov/pubmed/28240974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.6544
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items